Volume 27, Issue 120 (January & February 2019)                   J Adv Med Biomed Res 2019, 27(120): 51-54 | Back to browse issues page


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Hormati A, Sarkeshikian S S, Alemi F, Iranikhah A, Ghodoosi M, Gharehbeglou M, et al . Coexistence of Gastric Gastrointestinal Stromal Tumor and Ulcerative Colitis in Patient with Dyspepsia and Rectorrhagia: A Case Report. J Adv Med Biomed Res 2019; 27 (120) :51-54
URL: http://journal.zums.ac.ir/article-1-4984-en.html
1- Gastroenterology and Hepatology Disease Research Center, Qom University of Medical Sciences, Qom, Iran
2- Dept.of Pathology, Qom University of Medical Sciences, Qom, Iran
3- Dept.of Gastroenterolog,Valiasr Hospital, Zanjan University of Medical Sciences, Zanjan, Iran
4- Gastroenterology and Hepatology Disease Research Center, Qom University of Medical Sciences, Qom, Iran , ghadir1968@gmail.com
Abstract:   (146625 Views)

Case presentation: A 32-year-old man with dyspepsia and rectorrhagia dating back 3 weeks underwent endoscopy and colonoscopy. Upper GI endoscopy revealed a 2×2cm submucosal lesion at the gastric body. Endoscopic ultrasonography confirmed GIST and surgery was recommended. Colonoscopy diagnosed left side inflammatory bowel disease (IBD) (ulcerative colitis). Abdominal CT scan and sonography had no apparent abnormality. The pathology report confirmed low grade, spindle type gastrointestinal stromal tumor (GIST). Treatment was started with oral Mesalazine and Asacol enema. As the abdominal and pelvic CT showed no metastasis, a complete surgical resection of the tumor was performed and in a 6-month follow up, the patient had no problem.
Discussion: IBD patients are at an increased risk of malignancy due to chronic inflammatory state and the use of immunomodulator agents. Thus, the risk of malignancies at the beginning of the disease is low and its occurrence is rare.  The most common cancer in such patients is adenocarcinoma and GIST is somehow rare, with a small number reported in literature. Since the presence of GIST is not related to disease activity, it should be considered in differential diagnosis in patients with controlled IBD who are still symptomatic.

Full-Text [PDF 316 kb]   (156953 Downloads) |   |   Full-Text (HTML)  (3660 Views)  

The most common cancer in such patients is adenocarcinoma and GIST is somehow rare, with a small number reported in literature. Since the presence of GIST is not related to disease activity, it should be considered in differential diagnosis in patients with controlled IBD who are still symptomatic.


Type of Study: Case report | Subject: Clinical medicine
Received: 2017/12/28 | Accepted: 2018/10/18 | Published: 2019/09/16

References
1. Steigen SE, Eide TJ. Gastrointestinal stromal tumors (GISTs): a review. APMIS. 2009; 117: 73-86. [DOI:10.1111/j.1600-0463.2008.00020.x] [PMID]
2. Katz SC, DeMatteo RP. Gastrointestinal stromal tumors and leiomyosarcomas. J Surg Oncol. 2008; 97: 350-9. [DOI:10.1002/jso.20970] [PMID]
3. Medeiros F, Corless CL, Duensing A, et al. KIT-negative gastrointestinal stromal tumors: proof of concept and therapeutic implications. Am J Surg Pathol. 2004; 28: 889-94. [DOI:10.1097/00000478-200407000-00007] [PMID]
4. Colombel JF, Sandborn WJ, Reinisch W, et al. Infliximab, azathioprine, or combination therapy for Crohn's disease. N Engl J Med. 2010; 362: 1383-95. [DOI:10.1056/NEJMoa0904492] [PMID]
5. Ransofoff DF: Colon cancer in ulcerative colitis. Gastroenterology. 1998; 94: 1089-91 [DOI:10.1016/0016-5085(88)90573-2]
6. Pfeffel F, Stiglbauer W, Depisch D, Oberhuber G, Raderer M, Scheithauer W. Coincidence of Crohn's disease and a high-risk gastrointestinal stromal tumor of the terminal ileum. Digestion. 1999; 60(4): 363-6. [DOI:10.1159/000007684] [PMID]
7. Toader E, Ciortescu I. Is there a risk for lymphoma or extracolonic cancer in patients with inflammatory bowel disease? Rev Med Chir Soc Med Nat Iasi. 2013; 117(2): 368-74.
8. Hormati A, Ghadir MR, Sarkeshikian SS, et al. Coexistence of crohn's disease and hodgkin's lymphoma in a young man with rectorrhagia. Jundishapur J Chronic Dis Care. 2017; 6(2): e42794. [DOI:10.5812/jjcdc.42794]
9. Ruffolo C, Massani M, Rossi S, Caratozzolo E, Antoniutti M, Bassi N. Adenocarcinoma and GIST in ulcerative colitis. Int J Colorectal Dis. 2010; 25(8): 1027-8. doi: 10.1007/s00384-010-0905-x. [DOI:10.1007/s00384-010-0905-x] [PMID]
10. Mijandrusić Sincić B, Kovac D, Jasić M, Grbas H, Uravić M, Depolo A. Crohn's disease and a gastrointestinal stromal tumor in an 81-year-old man-a rare coincidence. Zentralbl Chir. 2005; 130: 597-99. [DOI:10.1055/s-2005-918206] [PMID]
11. Pellino G1, Marcellinaro R2, Candilio G3, et al. The experience of a referral centre and literature overview of GIST and carcinoid tumours in inflammatory bowel diseases. Int J Surg. 2016; 28: S133-41. [DOI:10.1016/j.ijsu.2015.12.051] [PMID]
12. Stahl TJ, Schoetz DJ, Roberts PL, Coller JA, Murray JJ, Silverman MC, Veidenheimer MC. Crohn's disease and carcinoma: Increased justification for surveillance? Dis Colon Rectum. 1992; 35: 850-6. [DOI:10.1007/BF02047872] [PMID]
13. Laukhuf F, Tischer KH, Strobel K, Wietholtz H. Crohn's disease and stromal sarcoma of the small bowel- a rare coincidence. Zeitschrift fur Gastroenterologie. 2002; 40(3): 193-6. [DOI:10.1055/s-2002-22320] [PMID]
14. Vassos N, Agaimy A, Hohenberger W, Croner RS. Coexistence of gastrointestinal stromal tumours (GIST) and malignant neoplasms of different origin: prognostic implications. Int J Surg. 2014; 12(5): 371-7. [DOI:10.1016/j.ijsu.2014.03.004] [PMID]
15. Grieco A, Cavallaro A, Potenza AE. Gastrointestinal stromal tumor (GIST) and ulcerative colitis. J Exp Clin Cancer Res. 2002; 21(4): 617-20. [Article] [PMID]

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2025 CC BY-NC 4.0 | Journal of Advances in Medical and Biomedical Research

Designed & Developed by : Yektaweb